Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)NewsBilanz/GuVDividende/HVZertifikateDepot/Watchlist
Times + SalesChart-AnalyseAnalysenSchätzungenTermineOptionsscheinemyHome
BörsenplätzeChartvergleichKursziele ProfilKnock-OutsSenden
OrderbuchRealtime Stuttgart  InsidertradesFonds 
HistorischRealtime PushmyNews im ForumAnleihen
Kaufen
Verkaufen
Diese Aktie wird nicht mehr gehandelt
  • Sprache:
  • Alle
  • DE
  • EN
  • Sortieren:
  • Datum
  • meistgelesen
20.06.13
EpiCept Issues Notice of Special Meeting of Stockholders on August 6 to Approve Important Aspects of the Proposed Merger with Immune Pharmaceuticals (Businesswire)
03.06.13
EpiCept Announces New Crolibulin Data Presented at ASCO 2013 Support Further Evaluation in Anaplastic Thyroid Cancer (Businesswire)
22.05.13
CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013 (Businesswire)
20.05.13
EpiCept Reports First Quarter 2013 Operating and Financial Results (Businesswire)
28.02.13
EpiCept Reports Fourth Quarter and Full Year 2012 Operating and Financial Results (Businesswire)
21.02.13
Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis (Businesswire)
12.02.13
EpiCept Corporation and Immune Pharmaceuticals Amend Merger Agreement (Businesswire)
07.02.13
EpiCept Corporation to Present at the 15th BIO CEO & Investor Conference (Businesswire)
31.01.13
EpiCept Reports Total Shares Outstanding (Businesswire)
09.01.13
Daniel Teper of Immune Pharmaceuticals to Present at the 6th Annual OneMedForum (Businesswire)
14.11.12
EpiCept Reports Third Quarter 2012 Operating and Financial Results (Businesswire)
12.11.12
EpiCept to Report Third Quarter 2012 Operating and Financial Results on November 14, 2012 (Businesswire)
08.11.12
Immune Pharmaceuticals and EpiCept Corporation Agree to Merge (Businesswire)
25.09.12
EpiCept Corporation Raises $0.8 Million from Immediate Exercise of Re-priced Warrants (Businesswire)
05.09.12
EpiCept Regains Rights to Azixa® from Licensee Myrexis (Businesswire)
31.08.12
EpiCept Amends Loan and Security Agreement (Businesswire)
30.08.12
EpiCept Announces Changes to Its Board of Directors (Businesswire)
21.08.12
EpiCept Announces Resignation of CEO Jack Talley (Businesswire)
08.08.12
EpiCept Reports Second Quarter 2012 Operating and Financial Results (Businesswire)
02.08.12
EpiCept to Report Second Quarter 2012 Operating and Financial Results on August 8, 2012 (Businesswire)
19.06.12
EpiCept Transfers Ceplene Responsibilities in European Union and Sells License Rights to Meda (Businesswire)
12.06.12
EpiCept Corporation to Present at 2012 BIO International Convention (Businesswire)
04.06.12
EpiCept Corporation Receives Scientific Advice from European Medicines Agency for AmiKet™ CIPN Program (Businesswire)
09.05.12
EpiCept Reports First Quarter 2012 Operating and Financial Results (Businesswire)
04.05.12
EpiCept to Report First Quarter 2012 Operating and Financial Results on May 9, 2012 (Businesswire)
30.04.12
EpiCept Makes Required Swedish Regulatory Disclosure (Businesswire)
10.04.12
EpiCept’s AmiKet™ Receives Fast Track Designation from FDA (Businesswire)
04.04.12
EpiCept’s Licensed Compound EP1013 Identified as a New Drug Candidate for Treatment of Late-Stage Viral Hepatitis (Businesswire)
29.03.12
EpiCept to Raise $1.1 Million in Registered Direct Offering (Businesswire)
14.03.12
EpiCept Corporation to Present at the BIO-Europe Spring 2012 Event (Businesswire)
29.02.12
EpiCept Reports Fourth Quarter and Full Year 2011 Operating and Financial Results (Businesswire)
23.02.12
EpiCept Corporation to Report Fourth Quarter and Full Year 2011 Operating and Financial Results on February 29, 2012 (Businesswire)
09.02.12
EpiCept to Raise $2 Million in Registered Direct Offering (Businesswire)
08.02.12
EpiCept to Present at the 14th Annual BIO CEO & Investor Conference (Businesswire)
07.02.12
EpiCept Files for AmiKet™ Fast Track Designation (Businesswire)
24.01.12
EpiCept Corporation Confirms Engagement of SunTrust Robinson Humphrey to Include Evaluation of Potential Sale Transactions (Businesswire)
23.01.12
EpiCept Corporation Receives Finalized FDA Guidance for AmiKet™ Phase III CIPN Program and Regulatory Strategy (Businesswire)
09.01.12
EpiCept Corporation Reduces Exercise Price and Extends Expiration Date of June 2010 Series B Warrants (Businesswire)
09.01.12
EpiCept Corporation Engages SunTrust Robinson Humphrey to Advise on Strategy to Maximize AmiKet™ Potential (Businesswire)
05.01.12
EpiCept to Present at Two Upcoming Industry Conferences (Businesswire)
Seite: 12

EpiCept News

EpiCept News: auf dieser Seite finden Sie alle EpiCept News und Nachrichten zur EpiCept Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch EpiCept News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um EpiCept News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.

Meistgelesene EpiCept News

Keine Nachrichten gefunden.
Weitere EpiCept News

EpiCept Peer Group News

Keine Nachrichten gefunden.